300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Mobile
Oil and Gas
Payments
Retail
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Finance
Art
Social Media
Franchise
Internet
Manufacturing
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
FinTech
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Lesotho
Madagascar
Nepal
Russian Federation
Pakistan
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Côte d'Ivoire
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Moldova
Uruguay
Seychelles
Botswana
South Africa
Paraguay
France
Ghana
Denmark
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Portugal
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Kenya
Mali
Latvia
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Barbados
Angola
Belgium
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Qatar
Ecuador
Bulgaria
Bahamas
Bolivia
Belize
Algeria
Belarus
Finland
Bahrain
Italy
Jersey
Estonia
Hungary
Grenada
Israel
Honduras
Liechtenstein
Lithuania
Cambodia
Lebanon
Iceland
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in China (November 2026)

The most active venture capital funds investing in China Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in China Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Qiming Venture Partners
VC Fund
62 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Medical $4M–$120M
HSG
VC Fund
49 China, United States, Singapore Series A, Series B, Seed Artificial Intelligence, Health Care, Software $2M–$200M
BioVenture
VC Fund
40 China, United States, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Medical $4.4M–$85M
Matrix Partners China
VC Fund
34 China, United States, Singapore Series A, Series B, Seed Health Care, Software, Information Technology $1.2M–$137M
Legend Capital
VC Fund
32 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $1.6M–$200M
Med-Fine Capital
VC Fund
29 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $3M–$60M
Shenzhen Capital Group
VC Fund
27 China, United States, Japan Series A, Series B, Seed Manufacturing, Health Care, Software $1.4M–$141M
IDG Capital
VC Fund
26 China, United States, Singapore Series A, Series B, Seed Internet, Software, E-Commerce $600k–$110M
Lilly Asia Ventures
VC Fund
26 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$308M
Frees Fund
VC Fund
26 China, United States, Singapore Series A, Angel, Seed Artificial Intelligence, Health Care, Medical $452k–$28M
Northern Light Venture Capital
VC Fund
24 China, United States, South Korea Series A, Series B, Venture - Series Unknown Health Care, Medical, Biotechnology $1.5M–$60M
Cowin Capital
VC Fund
23 China, United States, Hong Kong Series A, Series B, Seed Manufacturing, Health Care, Semiconductor $1.4M–$51M
Shanghai Biomedical Industrial Equity Investment Fund
VC Fund
23 China, United States, Hong Kong Series A, Seed, Series B Health Care, Medical, Biotechnology $8M–$159M
Taiyu Investment
VC Fund
22 China Seed, Series A, Angel Medical, Health Care, Biotechnology $434k–$100M
Puhua Capital
VC Fund
22 China, United Kingdom, United States Series A, Series B, Seed Manufacturing, Health Care, Medical $1.5M–$103M
Prox Ventures
VC Fund
22 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$30M
Legend Star
VC Fund
21 China, United States, France Series A, Seed, Angel Health Care, Medical, Robotics $244k–$52M
Cowin Venture
VC Fund
21 China, United States, Hong Kong Series A, Angel, Series B Health Care, Biotechnology, Medical $52k–$257M
Longpan Investment
VC Fund
20 China, United States, Cayman Islands Series A, Seed, Series B Health Care, Medical, Biotechnology $14M–$60M
Marathon Venture Partners
VC Fund
20 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.5M–$142M
Lenovo Capital
VC Fund
19 China, Hong Kong, United States Series A, Seed, Series B Manufacturing, Artificial Intelligence, Software $1.4M–$150M
ZhenFund
VC Fund
17 China, United States, Singapore Seed, Series A, Angel Software, Artificial Intelligence, Information Technology $98k–$22M
CDH Investments
VC Fund
17 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $2.9M–$220M
Highlight Capital
VC Fund
17 China, United States, South Korea Series A, Series B, Seed Health Care, Biotechnology, Medical $3.1M–$84M
ZSVC
VC Fund
16 China, United States, India Series A, Seed, Series B Manufacturing, Medical, Health Care $1.4M–$84M
Dalton Venture
VC Fund
16 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $512k–$50M
Fortune Venture Capital
VC Fund
16 China, Japan, United States Series A, Series B, Seed Manufacturing, Information Technology, Software $462k–$73M
Huagai Capital
VC Fund
15 China, United States, Hong Kong Series A, Series B, Angel Health Care, Biotechnology, Medical $444k–$90M
BioTrack Capital
VC Fund
15 China, United States, Singapore Series A, Series B, Seed Biotechnology, Health Care, Medical $14M–$168M
Share Capital
VC Fund
15 China, United States, Colombia Series A, Series B, Seed Health Care, Medical, Biotechnology $161k–$93M
Hillhouse Investment
VC Fund
14 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Medical $3M–$300M
EFung Capital
VC Fund
14 China, United States, India Series A, Series B, Series C Health Care, Biotechnology, Medical $1.4M–$100M
Haiyuan Capital
VC Fund
14 China Series A, Seed, Angel Manufacturing, Medical, Semiconductor $432k–$18M
Shunwei Capital
VC Fund
14 China, United States, India Series A, Series B, Seed Manufacturing, Software, Artificial Intelligence $1M–$74M
Oriza Seed Capital (Oriza Yuandian)
VC Fund
14 China, United States, Singapore Series A, Seed, Angel Manufacturing, Health Care, Medical $223k–$60M
Oriza Holdings
VC Fund
13 China, United States, Canada Series A, Series B, Seed Manufacturing, Health Care, Biotechnology $1.5M–$100M
Oriental Fortune Capital
VC Fund
13 China, United States, Hong Kong Series A, Series B, Seed Manufacturing, Software, Artificial Intelligence $1.5M–$100M
Sinovation Ventures
VC Fund
13 China, United States, Hong Kong Series A, Seed, Series B Software, Artificial Intelligence, Health Care $882k–$74M
Sherpa Healthcare Partners
VC Fund
13 China, United States, Kenya Series A, Series B, Series C Biotechnology, Health Care, Medical $7.2M–$128M
Cenova
VC Fund
13 China, United States, Hong Kong Series B, Series A, Series C Medical, Health Care, Biotechnology $2.9M–$100M
Pan-Lin Capital
VC Fund
13 China, United States, Canada Series A, Seed, Series B Health Care, Biotechnology, Medical $1.4k–$58M
Kaitai Capital
VC Fund
12 China, United States, Singapore Series A, Seed, Series B Biotechnology, Health Care, Pharmaceutical $1.4M–$57M
Addor Capital
VC Fund
12 China, Hong Kong, United States Series A, Series B, Venture - Series Unknown Manufacturing, Semiconductor, Electronics $1.4M–$145M
K2VC
VC Fund
12 China, United States, Hong Kong Angel, Series A, Seed E-Commerce, Manufacturing, Software $417k–$25M
Green Pine Capital Partners
VC Fund
11 China, United States, Canada Series A, Angel, Series B Artificial Intelligence, Software, Biotechnology $432k–$150M
Shenzhen Guozhong Venture Capital Management
VC Fund
11 China Series A, Series B, Seed Manufacturing, Health Care, Medical $441k–$100M
Sunland Fund
VC Fund
11 China Series A, Series B, Seed Health Care, Medical, Medical Device $1.4M–$28M
Beijing Huafang Investment
VC Fund
11 China Series A, Seed, Angel Biotechnology, Medical, Biopharma $13M–$30M
Plum Ventures
VC Fund
11 China, United States, Hong Kong Series A, Angel, Seed Manufacturing, E-Commerce, Internet $441k–$28M
Tiantu Capital
VC Fund
11 China, United States, Japan Series A, Series B, Seed Food and Beverage, E-Commerce, Medical $1.5M–$146M
Access all 3837 VC funds in China Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 62 investments in China Medical startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 1233
  • Round size: Series A $4M–$45M; Series B $7.6M–$90M; Series C $12M–$120M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fresh fund, raised $8M in 2026

Portfolio highlights

  • Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Show all investments...

HSG
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 49 investments in China Medical startups

HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 1144
  • Round size: Seed $2M–$50M; Series A $2M–$100M; Series B $10M–$200M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $2.5B in 2024

Portfolio highlights

  • Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
  • Xinghuo Chenguang — Xinghuo Chenguang is a hard-tech company focusing on semiconductor chips and optoelectronic interconnect technologies.
  • Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 40 investments in China Medical startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greater development space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services. Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns. Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise. By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 192
  • Round size: Seed $7.9M–$41M; Series A $4.4M–$47M; Series B $7.1M–$85M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $204M in 2016

Portfolio highlights

  • Inno Medicine — Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 34 investments in China Medical startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies. Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have gone on to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors. Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 763
  • Round size: Seed $1.2M–$74M; Series A $2.3M–$52M; Series B $9.5M–$137M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $92M in 2023

Portfolio highlights

  • Camera360 — Camera360 is a mobile photo editing and selfie camera app that offers filters, beautification, and creative effects. It uses AI-based features like face detection, skin smoothing, beautification, and auto-enhancement to improve photos. The app also includes AI-powered effects such as makeup filters, portrait retouching, and scene optimization for images.
  • Hefei Keye — Hefei Keye is a private company that specializes in producing various general-purpose mechanical items and vacuum machines. The organization places a high priority on technological innovation and has purchased a variety of cutting-edge tools to satisfy its R&D requirements.
  • Hydrogen Phoenix Technology — Hydrogen Phoenix Technology specializes in the research, development, and industrialization of energy technologies.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 32 investments in China Medical startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China. Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in China or on markets related to China. Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services. Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc. As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 543
  • Round size: Series A $1.6M–$74M; Series B $12M–$107M; Series C $15M–$200M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
  • Huixin Bio — Huixin Bio is a developer of exosome purification products and early cancer detection technology.
  • Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 29 investments in China Medical startups, 6 in the past 12 months

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $8M–$60M; Series A $3M–$40M; Series B $12M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2019

Portfolio highlights

  • Deepin Medical — Deepin Medical is dedicated to developing intelligent gadgets that address all aspects of surgery under a microscope.
  • Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
  • Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 27 investments in China Medical startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB, and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 688
  • Round size: Seed $1.4M–$29M; Series A $1.6M–$100M; Series B $7.5M–$141M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Prosemi — Pusenmei is a precision micro-resistance current sensor developer company committed to delivering professional and diverse precision micro-resistance current detecting resistors and circuit protection solutions.
  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Waker Biology — Weike Bio is a gene therapy drug development company.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 26 investments in China Medical startups, 74 in the past 12 months

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

Show more...

Investment focus

  • Industry: Internet, Software, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 1340
  • Round size: Seed $600k–$50M; Series A $1.6M–$100M; Series B $6.2M–$110M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • DeepSeek — DeepSeek is an artificial intelligence company that develops language models, AI-powered applications, and developer tools for information processing, problem-solving, and software development. Its product portfolio includes a conversational assistant for answering questions, generating text, explaining concepts, writing code, and supporting analytical tasks. The company provides models such as DeepSeek V4.1 Flash and DeepSeek V4, which support reasoning, programming, and other general-purpose AI applications. Through its API platform, DeepSeek enables developers and businesses to integrate its models into software, automated workflows, and AI-powered services. It also publishes technical research, model documentation, and open-weight model releases that allow developers to explore and deploy supported models in their own environments. DeepSeek's services serve individual users, programmers, researchers, and organizations seeking AI tools for everyday tasks, technical development, and application building.
  • NeuroXess — NeuroXess is an invasive brain-computer interface with high-density flexible brain electrodes aimed at brain research and disease diagnosis.
  • PhotonPay — Founded in 2015, PhotonPay is a digital financial infrastructure provider offering global payment solutions to businesses. Our innovative core products include Global Accounts, Card Issuing, Online Payments, Payouts, FX Management and Embedded Finance. PhotonPay has become a Mastercard issuer in Hong Kong and the fintech card issuer in the GreaterChina region of Discover® Network. With a strong compliance culture and technological innovation capabilities, PhotonPay is building a digital payment network to take the friction out of global payments and enhance operational efficiency for businesses operating on a global scale. Headquartered in Hong Kong and providing localized services through nine international offices, PhotonPay partners with a network of top-tier banks and global financial institutions and serves more than 200,000 customers globally.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 26 investments in China Medical startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 256
  • Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $30M–$308M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
  • NeuShen Therapeutics — We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
  • Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology company specializing in the discovery and development of next-generation small-molecule drugs for oncology treatment .
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 26 investments in China Medical startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stage startups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Medical
  • Stage:Series A, Angel, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 245
  • Round size: Seed $1.4M–$14M; Angel $452k–$10M; Series A $1.6M–$28M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $144M in 2015

Portfolio highlights

  • Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
  • Flysound — Flysound is a hearing technology company focused on making advanced AI-powered hearing aids affordable and accessible. Its products combine AI sound processing, Bluetooth connectivity, app-based personalization, and rechargeable convenience. With a focus on innovation, quality, and user-friendly design, Flysound aims to help people hear moreclearly and stay connected to everyday life.
  • Clarify intelligence — Clarify Intelligence is an artificial intelligence technology company focused on the research, development, and deployment of AI-driven software and intelligent solutions. The company specializes in developing foundational AI platforms, application software, and advanced AI algorithms to support a wide range of industry use cases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 24 investments in China Medical startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 411
  • Round size: Series A $2.9M–$40M; Series B $8.8M–$56M; Venture - Series Unknown $1.5M–$60M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 23 investments in China Medical startups

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 more successfully exit. The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Semiconductor
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 379
  • Round size: Seed $1.4M–$20M; Series A $1.6M–$51M; Series B $3.3M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2014

Portfolio highlights

  • Isabers — Isabers is a provider of advanced semiconductor integration technology and products, which can achieve inter-generational fusion of semiconductor materials and advanced packaging and can effectively solve the pain points of low yield, high cost, and limited performance of advanced semiconductor materials or devices, thus accelerating thedevelopment of the domestic semiconductor industry and quickly seizing the strategic high ground of international market competition.
  • Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
  • Digital China — Digital China is a robotics company focused on developing humanoid interactive robots that can break traditional boundaries and create emotionally resonated partners.
Show all investments...

Shanghai Biomedical Industrial Equity Investment Fund
VC Fund · Huangpu, Shanghai, China · 23 investments in China Medical startups

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 69
  • Round size: Seed $8M–$50M; Series A $14M–$43M; Series B $10M–$159M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • BioGeometry — BioGeo is an innovative digital startup that specializes in using generative AI in protein creation. BioGeo is dedicated to producing programmable proteins from scratch and utilizing them in synthetic biology and biomedicine by employing artificial intelligence-driven techniques to create links between protein sequence, structure, and function.
  • Surgerii Technology — Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design andintegration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.
  • Beyond Therapeutics — Beyond Therapeutics employs its ExCEED technology to speed the discovery and development of novel medications for unmet therapeutic needs.
Show all investments...

Taiyu Investment
VC Fund · Beijing, Beijing, China · 22 investments in China Medical startups, 11 in the past 12 months

Taiyu Investment is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China

Investor stats

  • Total investments: 51
  • Round size: Seed $2.8M–$20M; Angel $434k–$100M; Series A $14M–$37M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Immunocan — Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs.
  • Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
  • Danuo Intelligent Technology — Danuo Intelligent Technology is dedicated to promoting the application of trustworthy AI in the life sciences field.
Show all investments...

Puhua Capital
VC Fund · Hangzhou, Zhejiang, China · 22 investments in China Medical startups

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United Kingdom, United States

Investor stats

  • Total investments: 284
  • Round size: Seed $2.5M–$30M; Series A $1.5M–$42M; Series B $3M–$103M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • MindMotion — MindMotion is an electronics company that supplies general-purpose 32-bit MCU products and solutions. The company's MM32 MCU products developed by the company based on the Arm Cortex-M series cores have four series of F/L/SPIN/W, more than 200 models, and a cumulative delivery of more than 300 million units, ranking in theforefront of local general-purpose 32-bit MCU companies.MindMotion was founded in 2011 and is headquartered in Shanghai, China.
  • Yitang Technology — Yitang Technology is a developer specializing in high-speed and high-precision placement machines. The company is dedicated to the research and development (R&D) of these advanced machines, as well as the industrialization of intelligent production line solutions.
  • Ganzhicao Technology — Gancao Doctor is an internet-based Traditional Chinese Medicine (TCM) company that helps clinics modernize their digital management and optimize operations. By using AI-assisted features, it enhances doctors' diagnostic and treatment abilities, delivering valuable benefits to doctors, patients, and clinics.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 22 investments in China Medical startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential. They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many years of remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 84
  • Round size: Seed $2.5M–$30M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Legend Star
VC Fund · Beijing, Beijing, China · 21 investments in China Medical startups, 16 in the past 12 months

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance. Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem. Legend Star is the independent early-stage investment arm of Legend Holdings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Robotics
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, France

Investor stats

  • Total investments: 194
  • Round size: Seed $975k–$16M; Angel $244k–$7.8M; Series A $1.5M–$52M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $127M in 2018

Portfolio highlights

  • CellWall — Cellwall is a desktop robot developer focused on the research, development, upgrade, and marketing of its initial product, CyboPal ONE.
  • Ubot Robotics — Ubot Robotics is dedicated to developing leg-and-foot bionic robots and has built a diverse range of bipedal, quadrupedal, hexapodal, and other leg-and-foot bionic robots.
  • Super Evolution Intelligence — Super Evolution Intelligence focuses on developing fundamental research models equipped with advanced meta-research capabilities, enabling them to analyze existing scientific knowledge, identify research gaps, formulate novel hypotheses, and autonomously explore complex problems.
Show all investments...

Cowin Venture
VC Fund · Beijing, Beijing, China · 21 investments in China Medical startups

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 106
  • Round size: Angel $52k–$1.9M; Series A $1.6M–$25M; Series B $3M–$257M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Genta Kyushu Bio — Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies.
  • Zhaomo Vacuum — Zhaomo Vacuum is an enterprise integrating R&D, production, commissioning, and service of vacuum chambers.
  • StringMotion Future — StringMotion Future focuses on the core technology research and development of tendon-inspired chord-driven robots, creating advanced robotic systems designed to deliver greater flexibility, precision, and efficiency for industrial and intelligent automation applications.
Show all investments...

Longpan Investment
VC Fund · Beijing, Beijing, China · 20 investments in China Medical startups, 12 in the past 12 months

Longpan Investment is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 44
  • Round size: Seed $14M–$60M; Series A $14M–$32M; Series B $14M–$37M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Jingling Zhikang — Jingling Zhikang is technology company specializing in the intersection of medical rehabilitation, robotics, and embodied artificial intelligence. The company focuses on developing intelligent rehabilitation bionic hands and upper-limb prosthetics.
  • Hanyue New Materials — Hanyue Advanced Materials is a high-tech company that specializes in single-use biopharmaceutical solutions.
  • Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Show all investments...

Marathon Venture Partners
VC Fund · Shanghai, Shanghai, China · 20 investments in China Medical startups

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 63
  • Round size: Seed $7M–$13M; Series A $1.5M–$29M; Series B $14M–$142M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Fungifuture — Fungifuture is a synthetic biomaterials company specializing in the research and development and production of fungal fiber materials.
  • Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
  • Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lenovo Capital
VC Fund · Beijing, Beijing, China · 19 investments in China Medical startups

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Software
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 347
  • Round size: Seed $1.4M–$65M; Series A $1.5M–$74M; Series B $8M–$150M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $500M in 2016

Portfolio highlights

  • SemiGraph — SemiGraph focuses on the research, development, and implementation of "3D intelligent interaction + ultimate aesthetics."
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
Show all investments...

ZhenFund
VC Fund · Beijing, Beijing, China · 17 investments in China Medical startups

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. We believe that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 815
  • Round size: Seed $98k–$11M; Angel $425k–$3M; Series A $863k–$22M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • XHEART — XHEART specializes in the designing and development of computing chips for physical AI applications.
  • Snowplus — SNOWPLUS is an e-cigarette brand that provides users with e-cigarette products through a combination of online and offline sales models. The products are available in 12 different types of flavors. The products use TrueFeel honeycomb ceramic atomization technology and Aeroflow intake. Technology; In addition to reference to the existing food-gradestandards in China, Xuejia has also passed a number of third-party certifications in terms of safety. The core components such as atomizing core and cigarette holder comply with the highest medical safety standards of the FDA and the European Union.
  • Futuring Robot — Futuring Robot is a developer of dual-arm home service robots focusing on C-end home scenarios.
Show all investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 17 investments in China Medical startups, 42 in the past 12 months

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for many years focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 344
  • Round size: Series A $2.9M–$100M; Series B $14M–$149M; Series C $20M–$220M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • MoSense — MoSense develops full-body multimodal tactile perception systems for humanoid and other robots.
  • Jinkong Technology — Jinkong Technology focuses on space robotics, with a long-term strategic vision centered on space manufacturing. The company aims to advance robotic technologies that enable in-space assembly, manufacturing, and infrastructure development, contributing to the future of sustainable human activities in space.
  • Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 17 investments in China Medical startups, 31 in the past 12 months

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 183
  • Round size: Seed $10M–$84M; Series A $3.1M–$73M; Series B $7.6M–$70M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Elem Biotech — Elem Biotech operates as a biotechnology company. Elem Biotech focus on research and development of high-throughput cell editing technology to new drug discovery and basic research.
  • Shengxia Guangnian — Shengxia Guangnian is an investment management firm.
  • Ruide Pharmaceutical — Ruide Pharmaceutical is an integrated enterprise focusing on the research, development, production, and sales of companion animal (pet) pharmaceuticals in the consumer healthcare sector.
Show all investments...

ZSVC
VC Fund · Beijing, Beijing, China · 16 investments in China Medical startups, 14 in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, India

Investor stats

  • Total investments: 148
  • Round size: Seed $1.4M–$4M; Series A $1.5M–$21M; Series B $3.1M–$84M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Tpson — Tpson is a Smart Hardware company.
  • Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
  • HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 16 investments in China Medical startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 144
  • Round size: Seed $512k–$5M; Series A $3M–$17M; Series B $3.2M–$50M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Vibronix — Vibronix innovates for Precision Healthcare with spectroscopic imaging, optical & acoustic sensing, and machine learning.
  • PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
  • Yuanshi Technology — Yuanshi Technology concentrates on the study and advancement of AI virtual cell technology.
Show all investments...

Fortune Venture Capital
VC Fund · Shenzhen, Guangdong, China · 16 investments in China Medical startups

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech. Fortune Capital is ranked among the highest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc. In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, Japan, United States

Investor stats

  • Total investments: 342
  • Round size: Seed $462k–$73M; Series A $1.5M–$42M; Series B $3.3M–$57M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $860M in 2021

Portfolio highlights

  • Sandstone — SandStone is a product, solution and service provider focused on next-generation data storage (ServerSAN), which is dedicated to helping users cope with data storage, traffic and data management complexity, helping users build storage virtualization and Computation of virtualization as the core cloud computing infrastructure environment, andgradually provide data processing, mining, analysis and intelligence in the field of big data professional systems and services.
  • Sungen Biomedical — Sungen Biomedical is an innovative antibody drug R&D enterprise. It has established international standard technology platforms and original biological macromolecular R&D pipelines. Their focus includes therapeutic drugs for cardiovascular and cerebrovascular diseases, tumors, and more.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 15 investments in China Medical startups, 10 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 155
  • Round size: Angel $444k–$15M; Series A $1.5M–$73M; Series B $8.5M–$90M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • SeaArt — SeaArt AI is an all-in-one AI creativity community for art, videos, audio, and AI chats, where creators collaborate, spark inspiration, and grow together.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 15 investments in China Medical startups, 19 in the past 12 months

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from early research to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 94
  • Round size: Seed $15M–$168M; Series A $14M–$45M; Series B $15M–$147M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Taiyi Quantum — Taiyi Quantum is dedicated to encouraging innovation in the distribution and implementation of quantum computing technology, as well as developing sophisticated quantum algorithms and delivering tailored computing solutions for businesses and research institutes.
  • Convergen — Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases and other conditions driven by protein aggregates
  • Zhiyue Space Intelligence — Zhiyue Space Intelligence specializes in robotic brain and brain systems.
Show all investments...

Share Capital
VC Fund · Shenzhen, Guangdong, China · 15 investments in China Medical startups

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment and reagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Colombia

Investor stats

  • Total investments: 113
  • Round size: Seed $161k–$7.3M; Series A $1.4M–$18M; Series B $2.9M–$93M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • SuperDimension Power — SuperDimension is dedicated to creating leading embodied intelligent brains and robot bodies.
  • Help Therapeutics — Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Hillhouse Investment
VC Fund · Singapore, Central Region, Singapore · 14 investments in China Medical startups, 17 in the past 12 months

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies. Hillhouse is a full life-cycle private equity firm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 462
  • Round size: Series A $3M–$153M; Series B $14M–$219M; Series C $16M–$300M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $1.4B in 2023

Portfolio highlights

  • GOFO — GOFO provides last-mile parcel delivery and e-commerce logistics services for brands, marketplaces, and other business customers. Its services include parcel shipping, delivery through Delivery Service Partner networks, real-time package tracking, proof of delivery, customer support, and logistics coordination. GOFO uses automated sorting, warehousing, dispatch, route optimization, and linehaul operations to manage parcel movement from collection through final delivery.
  • KMC Solutions — Build global teams in the Philippines and Colombia with KMC's Employer of Record, recruitment, HR, payroll, and flexible office solutions.
  • EtherTech — EtherTech is a a company specializing in intelligent physical space infrastructure.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 14 investments in China Medical startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 86
  • Round size: Series A $1.4M–$36M; Series B $14M–$100M; Series C $14M–$74M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Glimmer Gene — Glimmer Gene develops a comprehensive gene editing and epigenetic toolkit with independent intellectual property rights.
  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
  • Reju Therapeutics — Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.
Show all investments...

Haiyuan Capital
VC Fund · Shenzhen, Guangdong, China · 14 investments in China Medical startups

Haiyuan Capital is a Shenzhen-based asset management company.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Semiconductor
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 80
  • Round size: Seed $1.4M–$15M; Angel $432k–$14M; Series A $1.4M–$18M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Sento — Shengtuo Semiconductor is a company that manufactures critical components and machine integrated systems for semiconductor manufacturing equipment.
  • Anxin Medical — Anxin Medical is a company dedicated to the research, development, production, and sales of innovative medical devices. The company focuses on advancing healthcare technology through continuous innovation, integrating cutting-edge science and engineering to create high-quality, reliable, and efficient medical products.
  • Feat-Aero Intelligent Technologies — Feat-Aero Intelligent Technologies is a specialized high tech enterprise designing advanced digital assembly equipment and robotics for the aerospace industry. Operating under a strategic Three One framework to drive automated manufacturing upgrades, the company offers a robust product suite including high precision drilling, riveting, and digital twin systems.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 14 investments in China Medical startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internet sectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, India

Investor stats

  • Total investments: 635
  • Round size: Seed $1M–$74M; Series A $1.5M–$41M; Series B $8.2M–$55M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
  • Geyuan Technology — Geyuan Technology operates as a cutting-edge brain science technology start-up.
  • Huixi Intelligent — Huixi Intelligent focuses on autonomous driving chips, and its products include chip computing platforms, autonomous driving software solutions, and development tool chains.
Show all investments...

Oriza Seed Capital (Oriza Yuandian)
VC Fund · Suzhou, Jiangsu, China · 14 investments in China Medical startups, 30 in the past 12 months

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcare field. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 154
  • Round size: Seed $223k–$25M; Angel $425k–$15M; Series A $1.4M–$60M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Weilan Deep-Sea — Weilan Deep-Sea focuses on the global underwater ocean observation field, with its core product being distributed underwater observation systems that integrate advanced sensing, data transmission, and intelligent monitoring technologies to enable long-term, wide-area, and high-precision observation of oceanographic, environmental, and geologicalprocesses.
  • Diver Innovation — Loon Innovation addresses a key limitation of traditional unmanned systems they typically operate in isolation, with aerial drones (“fly in the sky”) and underwater vehicles (“swim in the water”) functioning independently rather than as an integrated, coordinated system.
  • Thortime Technology — Thortime Technology is a hard-tech company specializing in the full-stack development, manufacturing, and delivery of Neutral Beam Injection systems for controllable nuclear fusion devices.
Show all investments...

Oriza Holdings
VC Fund · Suzhou, Jiangsu, China · 13 investments in China Medical startups, 34 in the past 12 months

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 230
  • Round size: Seed $4.5M–$44M; Series A $1.5M–$46M; Series B $10M–$100M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • MOSS Intelligence — MOSS Intelligence is a high-tech enterprise in China focusing on the research and commercialization of next-generation strong interactive basic models, aiming to advance the development of highly adaptive, multimodal AI systems that enable natural, context-aware human–machine interaction while supporting scalable applications across industries suchas education, enterprise services, robotics, and digital ecosystems.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 13 investments in China Medical startups

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatment and healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 343
  • Round size: Seed $1.5M–$100M; Series A $1.5M–$30M; Series B $3.2M–$73M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Memory tensor — Memory tensor designed with a focus on systematic innovation, grounded firmly in fundamental principles, serves as a powerful tool for scalable and adaptable intelligence. Its architecture emphasizes three core attributes: low cost, ensuring economic feasibility and accessibility; low illusion, reducing overfitting and minimizing hallucinations ormisleading outputs; and high generalization.
  • Langsilicon Technology — Langsilicon Technology is an electronic component R&D firm that specializes in the design, development, and sales of silicon-based passive components (capacitors, inductors, and resistors).
  • Lightwheel — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
Show all investments...

Sinovation Ventures
VC Fund · Beijing, Beijing, China · 13 investments in China Medical startups, 17 in the past 12 months

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market. It is formerly known as Innovation Works.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 426
  • Round size: Seed $882k–$14M; Series A $1.6M–$28M; Series B $3M–$74M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $203M in 2022

Portfolio highlights

  • Hemu Intelligent — Hemu Intelligent is an early-stage Industrial AI startup focused on mold physical AI, manufacturing semantic computing, and industrial application. By leveraging deep learning on mechanical drawings and digitizing the experiential workflows of master technicians, the company builds an "AI Craft Brain".
  • Yuanshi Technology — Yuanshi Technology concentrates on the study and advancement of AI virtual cell technology.
  • Ruilian Intelligent Computing — Ruilian Zhisuan is an AI computing infrastructure innovator that provides integrated hardware software solutions. Modeled after Google's Jupiter optoelectronic architecture, it features full stack OCS scheduling to replace traditional electronic switches with optical routing. This core technology drastically minimizes network latency andsystem power consumption for advanced AI calculation networks.
Show all investments...

Sherpa Healthcare Partners
VC Fund · Beijing, Beijing, China · 13 investments in China Medical startups

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Kenya

Investor stats

  • Total investments: 105
  • Round size: Series A $7.2M–$50M; Series B $15M–$100M; Series C $21M–$128M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Shenfu Jianxing — Shenfu Jianxing is a brain-computer interface developer. It focuses on minimally invasive implanted brain-spinal interface technology, with "minimally invasive + low latency + high integration" as its core, to build implantable brain-spinal neural stimulation systems.
  • Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
  • Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
Show all investments...

Cenova
VC Fund · Shanghai, Shanghai, China · 13 investments in China Medical startups, 8 in the past 12 months

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. Cenova Capital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 60
  • Round size: Series A $2.9M–$45M; Series B $13M–$61M; Series C $15M–$100M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
  • Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
  • Accro Bioscience — Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pan-Lin Capital
VC Fund · Shanghai, Shanghai, China · 13 investments in China Medical startups, 7 in the past 12 months

Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors. As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors. Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 84
  • Round size: Seed $1.4k–$28M; Series A $297k–$37M; Series B $7.3M–$58M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Lingdong Core Optics — Lingdong Core Optics is a high-tech firm that specializes in the design and implementation of silicon-based integrated optoelectronic chips.
  • Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Show all investments...

Kaitai Capital
VC Fund · Hangzhou, Zhejiang, China · 12 investments in China Medical startups, 8 in the past 12 months

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 163
  • Round size: Seed $1.4M–$20M; Series A $1.6M–$35M; Series B $10M–$57M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Micronano Core — Micro-nano core is committed to the development and production of the world's leading intelligent IoT AIoT SoC serialized chips, through the world's leading four core technologies: ultra-low-power chip architecture technology (to solve the problem of system standby power consumption), ultra-low power consumption Power consumptionclosed-loop adaptive near-threshold circuit technology (to solve the problem of chip running power consumption), ultra-low power consumption and high-precision sensor acquisition technology (to solve the problem of high precision and low power consumption of sensor signal acquisition) and high-efficiency embedded AI engine technology (solving the computing power and energy efficiency of embedded AI), creating a general/platform technology system for IoT chips and AIoT serialized chips, enabling IoT products, and significantly improving the low power consumption, low power consumption, and low power consumption of future IoT products High-precision detection and edge AI inference performance.
  • Guangyu Xinchen — Guangyu Xinchen is a semiconductor company that provides research and development of large-scale model chips for edge devices.
  • Panfeng Intelligence — Panfeng Intelligent has launched its first Agentic AI product, Moras, a groundbreaking solution designed to automate the entire content e-commerce process, from content creation and optimization to distribution, customer engagement, and performance analysis.
Show all investments...

Addor Capital
VC Fund · Nanjing, Jiangsu, China · 12 investments in China Medical startups

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Electronics
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 369
  • Round size: Series A $1.6M–$30M; Series B $12M–$145M; Venture - Series Unknown $1.4M–$101M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $241M in 2021

Portfolio highlights

  • Enorna — Enorna operates as an mRNA Contract Research, Development, and Manufacturing Organisation (CRDMO) driven by its proprietary Lipid Nanoparticle (LNP) delivery technology platform. The company offers end-to-end solutions spanning sequence design, preclinical Contract Research Organisation (CRO) tools, and commercial production services. Its value proposition centers on building an integrated nucleic acid industry ecosystem to optimize manufacturing processes and accelerate delivery of RNA therapeutics to patients.
  • Ibeki — Ibeki provides tiny photoelectric displacement sensors and servo control systems. eBridge uses the high precision and miniaturization of its precision motion drive technology to provide customers with a more complete technology portfolio, and has successfully transformed its core technology into a number of military and civilian products,particularly in aerospace, medical equipment, and intelligent control.
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
Show all investments...

K2VC
VC Fund · Beijing, Beijing, China · 12 investments in China Medical startups, 12 in the past 12 months

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Show more...

Investment focus

  • Industry: E-Commerce, Manufacturing, Software
  • Stage:Angel, Series A, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 341
  • Round size: Seed $448k–$14M; Angel $417k–$3.1M; Series A $1M–$25M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely actively investing — fresh fund, raised $31M in 2025

Portfolio highlights

  • Quantex — Quantex is committed to focusing on the next generation of information technology and integrated circuit fields, and is dedicated to the in-depth research and development of 3.2T/6.4T photonic integrated chips (PIC), optical modules and CPO (co-packaged optics) solutions, leading the localization of high-end optical transmission chips.
  • XinYang Micro — Xinyangwei is an early stage underwater sensing chip startup specializing in CMUT (Capacitive Micromachined Ultrasonic Transducer) technology. The company provides integrated acoustic sensing modules and 3D imaging components designed to give pool cleaning robots intelligent near field path planning and mapping capabilities.
  • Sequence Technology — Sequence Technology emphasizes in the production of polymer materials used in the semiconductor manufacturing process.
Show all investments...

Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 11 investments in China Medical startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special funds and have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises. GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 253
  • Round size: Angel $432k–$7.4M; Series A $1.5M–$60M; Series B $3M–$150M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $42M in 2025

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Ultimate Context — Ultimate Context is a high-tech enterprise specializing in the research, development, and innovation of AI video expression systems. The company is dedicated to advancing the field of intelligent video technology through the integration of artificial intelligence, computer vision, and deep learning.
  • Sungen Biomedical — Sungen Biomedical is an innovative antibody drug R&D enterprise. It has established international standard technology platforms and original biological macromolecular R&D pipelines. Their focus includes therapeutic drugs for cardiovascular and cerebrovascular diseases, tumors, and more.
Show all investments...

Shenzhen Guozhong Venture Capital Management
VC Fund · Shenzhen, Guangdong, China · 11 investments in China Medical startups, 16 in the past 12 months

Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund(SHENZHEN)LLP with a size of 6 Billion Yuan. Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhen venture capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%).

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 138
  • Round size: Seed $441k–$14M; Series A $1.5M–$41M; Series B $9.2M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Nova Fusion — Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors.
  • Xijia Medical — Xijia Medical is a brain science AI technology developer dedicated to individualized brain data analysis and brain disease research.
  • Ractigen Therapeutics — ractigen-hero-slider ractigen-row first odd first-in-class row-copy We Deliver First-in-Class Therapies We are an clinical-stage pharmaceutical company creating first-in-class therapies designed to boost expression of therapeutic genes in diseased cells. LEARN MORE > row-image ractigen-row even rnaa-technology row-image row-copy RNAa Technology: RNAa (RNA activation) is a platform technology to selectively turn genes on by using short
Show all investments...

Sunland Fund
VC Fund · Shanghai, Shanghai, China · 11 investments in China Medical startups

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 35
  • Round size: Seed $1.4M–$14M; Series A $1.6M–$16M; Series B $1.5M–$28M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
  • Insight Technology — Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more.
  • Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Show all investments...

Beijing Huafang Investment
VC Fund · Beijing, Beijing, China · 11 investments in China Medical startups, 9 in the past 12 months

Beijing Huafang Investment focuses on the investment and management of state-owned capital and its investment covers commercial real estate.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 28
  • Round size: Seed $13M–$14M; Series A $14M–$30M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • ClonOrgan — ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs.The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantationand creating the organ factory of the future.ClonOrgas was established in 2005 in Chengdu, Sichuan.
  • Glimmer Gene — Glimmer Gene develops a comprehensive gene editing and epigenetic toolkit with independent intellectual property rights.
  • Lingsheng Technology — Lingsheng Technology is a developer of embodied intelligent robots.
Show all investments...

Plum Ventures
VC Fund · Changzhou, Zhejiang, China · 11 investments in China Medical startups, 26 in the past 12 months

Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China.

Show more...

Investment focus

  • Industry: Manufacturing, E-Commerce, Internet
  • Stage:Series A, Angel, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 300
  • Round size: Seed $676k–$10M; Angel $441k–$3M; Series A $1.4M–$28M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $78M in 2019

Portfolio highlights

  • Ora-Orb — Ora-Orb isan AI-powered emotion technology and reflection platform that combines physical hardware, app integration, and a virtual character to serve as an interactive companion.
  • Ubinexus — Ubinexus focuses on the overall design capabilities of satellite communication payloads and satellite-based comprehensive digital processing technology to meet the multi-dimensional needs of low-orbit mega-constellation construction and provide users with the world's leading communication payload system.
  • Lingyan Technology — Lingyan Technology is the first domestic company to develop a bionic, dexterous facial intelligence system that achieves synchronized voice, lips, and eyes.
Show all investments...

Tiantu Capital
VC Fund · Shenzhen, Guangdong, China · 11 investments in China Medical startups

Tiantu Capital is a private equity and venture capital firm specializing in consumer-sector investments. The company provides investment management and financing services, supporting consumer brands across food, beverages, retail, healthcare, education, and lifestyle services. Its expertise in consumer markets and brand development helps portfolio companies accelerate growth, strengthen operations, and build sustainable business value.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 143
  • Round size: Seed $7M–$20M; Series A $1.5M–$16M; Series B $11M–$146M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2019

Portfolio highlights

  • Zdeer — Zdeer is a health tech brand focusing on artificial intelligence health and consumer medicine. It is committed to improving the health awareness of the whole people, while breaking the shackles of the traditional health industry, through continuous technological innovation and product innovation, to bring better-looking and better-use products toconsumers at a more affordable price.
  • KylinWay — The objective of KylinWay is to create and register a stand-alone high-tech business with a focus on the "hydrogen molecule new materials and anti-aging medicine track."
  • Billy Information — Mycooltv leverage advanced AI technology to create cost-effective solutions for premium hotel experiences. AI travel media network.
Show all investments...

Medical VC funding in China at a glance

Stats across 4k deals from 3.8k investors.

3.8k
investors
in China Medical startups
4k
deals
in China Medical startups
$7.2M
median round
in China Medical startups
39%
lead investors
lead at least one round
29%
Series A
most common funding stage

Access all 3837 VC funds in China Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 3837 VC funds investing in China Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists